Summary The reduced cellular uptake, and subsequent reduced nuclear availability, of cytotoxic agents is a factor in the resistance of mammalian cells to anti-cancer drugs that act by interaction with DNA. The whole cell uptake, nuclear binding and cytotoxicity of a DNA-specific ligand, Hoechst dye number 33342 (Ho342), has been studied in cytotoxic drug resistant variants of a murine tumour cell line. Cell lines showing various degrees of cross-resistance to adriamycin as a part of the phenotype of classical multi-drug resistance (MDR) demonstrated a reduction in intranuclear Ho342 content, up to a maximum of 35% of the level found in the parent as assessed by flow cytometry, despite similar levels of whole cell uptake determined using radiolabelled ligand. Ability to limit nuclear accessibility of Ho342 correlated closely with cellular resistance to Ho342 and to adriamycin. All drug resistant cell lines showed a significant increase in nuclear accessibility to Ho342 after verapamil treatment, including a methotrexate resistant cell line. The methotrexate resistant variant, not demonstrating MDR, showed reduced nuclear binding of Ho342 but increased cell kill associated with a propensity to develop a population of cells showing extra DNA replication in response to Ho342 exposure.
The clinical problem of acquired resistance to initially useful cytotoxic agents remains of major significance, and the investigation of cellular resistance mechanisms in tumour cell lines continues to generate hypotheses regarding this clinical situation. Prolonged exposure of mammalian cells in vitro to certain chemotherapeutic agents can result in the development of resistant sub-lines with cross-resistance to a number of functionally unrelated drugs. Such 'classical' multi-drug resistance (MDR) typically affects responsiveness to the anticancer drugs adriamycin (ADM), vincristine (VCR) and colchicine (COL). The MDR phenotype is thought to reflect increased active cellular efflux of these agents by a membrane located, energy-dependent transport mechanism involving Pglycoprotein (Gerlach et al., 1986; Endicott & Ling, 1989) . Presumably the mechanism of classical MDR effectively protects important intracellular targets by limiting their accessibility to these cytotoxic agents, an explanation satisfactory for the mitotic spindle inhibitors VCR and COL, but the situation is less clear for ADM, where significant cell membrane effects (Tritton & Yee, 1982) have been identified, in addition to DNA damaging activity (Zwelling et al., 1981) . Ideally an evaluation of intracellular target protection afforded by MDR should involve the use of an agent known to exert its cytotoxic effects predominantly through interaction with a single target (e.g. DNA), and whose delivery to this target can be monitored in individual cells.
We have investigated the relationship between cytotoxicity and the cellular capacity for intracellular target protection in cells showing MDR using a DNA specific ligand, Hoechst dye number 33342 (referred to as Ho342; Figure 1 ). Ho342 is a bisbenzimidazole dye with a specificity for non-intercalative binding at AT base pairs in DNA and minimal interaction with RNA (Latt & Stetten, 1976) . The related dye Hoechst 33258 (see Figure 1 ) has been used extensively as a DNA stain (Zimmer & Wahnert, 1986) . The more lipophilic derivative Ho342 is used as a vital nuclear stain in flow cytometry (Latt, 1979) but can induce DNA damage, mutations and cell death (Durand & Olive, 1982) . Human cells with putative deficiencies in DNA repair showed enhanced sensitivity to Ho342 (Smith, 1984) and a mammalian cell mutant with enhanced capacity to remove Ho342 from cellular DNA is highly resistant to the cytotoxic action of the dye (Smith et al. , 1988) . Thus the interaction of Ho342 with DNA appears to be an important factor in the cytotoxicity seen at higher concentrations of this agent (Zimmer & Wahnert, '986) . Unlike DNA-binding chemotherapeutic agents such as the anthracyclines (e.g. doxorubicin and daunomycin; Figure 1 ), the interaction of Ho342 with its target (the nucleus) can be assessed by exploiting the considerable fluorescence enhancement that occurs when bisbenzimidazole dyes bind noncovalently to the minor groove of the DNA double helix (Latt & Stetten, 1976) ; using flow cytometry (FCM), the resulting Ho342-DNA fluorescence monitors specifically nuclear dye uptake (Smith et al., 1985; Morgan et al., 1989 
Cell culture
The derivation of cytotoxic drug resistant variants from the parent mouse mammary tumour cell line, EMT6/Ca/VJAC, has been described previously (Twentyman et al., 1986a) . Briefly cells from the parent cell line were continuously exposed to the cytotoxic agent to which resistance was being induced; over approximately 6 weeks the cytotoxic drug concentration, chosen such that continued cell growth occurred, could be progressively increased until ultimately the resulting cell line was able to grow in a drug concentration highly inhibitory to the parent cell line. Variant cell lines showing different degress of resistance to the inducing agent have been produced by a continuation of the same process; for this study variant cell lines were used which had closely similar cell cycle characteristics (Table I) .
Cell lines were maintained in Eagles MEM with 20% new-born calf serum, supplemented with 2 mM glutamine, 100 IU ml-' penicillin and 100 mg ml-' streptomycin (all Gibco Biocult Ltd, Uxbridge, UK), at 37°C in 8% CO2 in air. EMT6 lines grew as attached monolayers, and were detached for experiments using a short exposure to trypsin/ EDTA in phosphate buffered saline (PBS).
Drug treatments
The exact concentrations of filter sterilised stock solutions of Ho342 (CP Laboratories, Bishop's Stortford, UK; Figure 1 ) were determined spectrophotometrically (molar extinction coefficient 4.1 104M-1 cm-' at 340 nm, pH 7.0). Adriamycin (Farmitalia Carlo Erba, St Albans, UK; Figure 1 ) was stored at -20°C at 500 mg ml-' in distilled water. Where indicated cells were exposed to VPL (Abbott Laboratories, Queenborough, UK) at 3.3 or 6.6 tLM for 30 min at 37°C before addition of Ho342. Cells were exposed to cytotoxic agents for 24 h under normal culture conditions (37°C, 92% air/8% C02, culture medium as above).
Ho342 accumulation Nuclear fluorescence assessment Attached cells in logarithmic phase of growth (1-3 x 106 per 9 cm dish), were exposed to fluorochrome under standard culture conditions at 37°C for 60 min before washing with buffer (10 mM Tris HCI, 100 mM NaCl, 10 mM EDTA, I mg ml-' bovine serum albumin, pH 8.0) at 4°C and rapid freezing on a dry ice/ethanol bath; immediately before FCM analysis cells were thawed at 37°C, resuspended in buffer at 2 x 105 cells ml-', and analysed using the MRC flow cytometer as described previously (Morgan et al., 1989) , importantly sub-cellular debris and cell clumps were excluded from analysis by electronic gating on the basis of light-scatter signals and pulse-shape analysis Ho342 with greater than 40% of radioactivity associated with a constituent that showed fluorescence enhancement with DNA, the remaining activity not being associated specifically with any other short UV-radiation-absorbing constituents.
Cytotoxic drug sensitivity testing Cell cycle perturbation Attached cells in logarithmic phase of growth were treated with cytotoxic agents in 6-well plates. Cultures were washed with PBS at 4°C immediately before trypsin/EDTA detachment, and cells were resuspended in full culture medium at a density of 2 x 105 ml-' before staining, using a rapid one-step DNA-staining technique for RNase digested cells using ethidium bromide (50 iLg ethidium bromide ml-', 0.125% Triton X-100, ribonuclease 0.5 g ml-'; 1:8 dilution with cell suspension; 10 min at room temperature: Taylor & Milthorpe, 1980) . Details of the analysis of cell suspensions by FCM, and the computer algorithm used to determine cell cycle distribution have been published previously (Watson et al., 1987) . Where cytotoxic treatment resulted in very pronounced disturbance of the normal cell cycle distribution, and virtual complete loss of the G, population, this algorithm could not be used satisfactorily; in such cases the frequency distributions were assessed by manual setting of gates according to the G,-and G2-DNA positions of the control sample (concordance of these two methods was in all cases checked at the lower cytotoxic drug concentrations). (Table I) , and showed no significant abnormality in ADM sensitivity, showed increased sensitivity to the cytotoxic actions of Ho342 compared to EMT6/P (RFIO 0.24).
Ho342 uptake study Ligand uptake in the six cell lines, as assessed by radiolabelled Ho342 accumulation in the whole cell (Figure 4) , showed a direct correlation with fluorochrome concentration (determined spectrophotometrically) over the range 10 nM to 10 1M (the maximum concentration limited by the ethanolic stock solution) for all cell lines. No significant differences in whole cell uptake were observed between the parent cell line (EMT6/P) and the resistant variants studied. At the highest Ho342 concentration studied (0I1JM) cellular dye loads were calculated to be no greater than approximately 40 and 42% respectively of the fluorescence produced in the parent cell line, the shape of the fluorescence/drug concentration curves suggesting failure to saturate Ho342-DNA binding sites even at the highest fluorochrome concentration used.
In the remaining three drug resistant lines, MR1.0, VRL.0 and 1215R, there was a reduction of fluorescence compared to that of the parent line, to between 80% and 90%. These differences could not be accounted for on the basis of variations in cell cycle phase distribution or cellular DNA content (Table I) The acute effect of VPL exposure on the binding of Ho032 to DNA was evaluated in the parent and resistant cell lines. EMT6/P cells exposed to VPL for 30 min before the addition of Ho342 showed a small increase (10%) of Ho342-DNA fluorescence, seen at 51&M Ho342 concentration only ( Figure  5) . Again, the lack of enhancement by VPL of the fluorescence produced by exposure of EMT6/P to 10I1M HO342 and the generation of HD cells). Figure 7 shows how these two parameters correlate for each cell line at given Ho342 concentrations. (Preliminary analyses indicated that G2 arrest alone was a relatively insensitive indicator of cell kill in EMT6 cell lines unless the concomitant arrest of cells in the HD phase was also considered.) A simple correlation between cell kill and cell cycle arrest might be expected to result in all values distributed along a straight line, with distance from the origin indicating either higher drug concentration or greater cellular sensitivity; EMT6/P cells demonstrated such a relationship (Figure 7 , continuous line). The ARl.0 cell line showed very similar distribution of results to EMT6/P, with a close association of cell cycle changes with cell kill up to 0.6 fractional cell kill. At high Ho342 concentrations cell cycle changes for EMT6/P were less than that expected for the degree of cell kill, suggesting that cell arrest was occurring in all phases of the cell cycle at these concentrations of dye, an effect observed with other cytotoxic agents (Barlogie et al., 1976) . The other cell lines examined showed divergence from the results of EMT6/P and ARl.0; CR2.0 and VRl.0 showed less cell cycle change for the same range of fractional cell kill, whereas 1215R showed an intermediate response. those cell lines that showed both cross-resis and changes associated with classical MDR ranking of DNA target protection (reduction Ho342 content) was the same as both the ran resistance to Ho342 (ARI.O>CR2.0 >> V and the ranking of resistance to ADM CR2.0 >> VRl.0> 1215R). These findings murine cell lines examined, previous observati al., Morgan et al., 1989) (Coley et al., 1989a,b ity. Given the This propensity may reflect a facility for DNA replication ) effect cytotoxwithout cytokinesis that has been observed in MTX resistant low cytometric variants of other cell lines (Schimke, 1986) .
cting resistance The present study shows that cell lines which differ in tinent to those Ho342 sensitivity do not always show the expected changes in cell cycle perturbation (Figure 7) . Thus some MDR cell lines (e.g. CR2.0 and VRl.0) may express modifications in pathways which affect ligand sensitivity additional to the protection of cellular DNA by the rapid cellular efflux of ligand molecules (e.g. ability to arrest cell cycle progression following the accumulation of genomic damage). The use of a DNA-specific ligand to analyse the relationship between cytotoxicity and nuclear location has revealed a spectrum of responses in drug resistant cells not predicted from their known degrees of expression of the classical MDR phenotype. We conclude that MDR can involve the modification of more than one cellular pathway controlling cytotoxic drug responsiveness, and that the flow cytometric approach described here may be useful in assessing such characteristics in human tumour biopsies.
